Full Name
Wan-Teck Darren Lim
Variants
Lim, W.-T.
 
Main Affiliation
 
 
Email
gmslwtd@nus.edu.sg
 

Publications

Results 1-20 of 22 (Search time: 0.01 seconds).

Issue DateTitleAuthor(s)
1Sep-2012A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancerBible, K.C.; Suman, V.J.; Menefee, M.E.; Smallridge, R.C.; Molina, J.R.; Maples, W.J.; Karlin, N.J.; Traynor, A.M.; Kumar, P.; Goh, B.C.; Lim, W.-T. ; Bossou, A.R.; Isham, C.R.; Webster, K.P.; Kukla, A.K.; Bieber, C.; Burton, J.K.; Harris, P.; Erlichman, C.
215-Aug-2011A phase II study of pazopanib in asian patients with recurrent/metastatic nasopharyngeal carcinomaLim, W.-T. ; Ng, Q.-S.; Ivy, P.; Leong, S.-S.; Singh, O.; Chowbay, B.; Gao, F.; Thng, C.H.; Goh, B.-C. ; Tan, D.S.-W.; Koh, T.S.; Toh, C.-K.; Tan, E.-H. 
33-Sep-2019Addressing cellular heterogeneity in tumor and circulation for refined prognosticationLim, Su Bin; Yeo, Trifanny ; Lee, Wen Di ; Bhagat, Ali Asgar S ; Tan, Swee Jin; Tan, Daniel Shao Weng ; Lim, Wan-Teck ; Lim, Chwee Teck 
427-Sep-2021Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signaturesTeng, Yvonne HF ; Quah, Hong Sheng ; Suteja, Lisda; Dias, Joao ML; Mupo, Annalisa; Bashford-Rogers, Rachael JM; Vassiliou, George S; Chua, Melvin LK; Tan, Daniel SW ; Lim, Darren WT ; Iyer, N Gopalakrishna 
52019Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).Fong, Pei Yuan; Tan, Sze Huey ; Lim, Darren Wan Teck ; Tan, Eng Huat ; Ng, Quan Sing ; Sommat, Kiattisa ; Tan, Daniel Shao Weng ; Ang, Mei Kim 
63-Aug-2021Bacillus Calmette-Guerin scar flare after an mRNA SARS-CoV-2 vaccineLim, Darren Wan-Teck ; Ng, Dorothy Hui Lin ; Low, Jenny Guek-Hong 
78-Oct-2019Compendiums of cancer transcriptomes for machine learning applicationsLim, Su Bin; Tan, Swee Jin; Lim, Wan-Teck ; Lim, Chwee Teck 
81-Sep-2021Dysfunctional bronchial cilia are a feature of Chronic Obstructive Pulmonary Disease (COPD)Biju Thomas ; Mariko Siyue Koh ; Chris O'Callaghan; JOHN ALLEN ; Andrew Rutman; Rob Hirst; John Connolly ; Su Ying Low ; Ong Thun How ; Loo Chian Min ; Darren Wan Teck Lim ; Oon Lin Ean Lynette ; Qixian He; Oon Hoe Teoh ; Therese Lapperre 
918-Oct-2021Erythema over the site of a Bacillus Calmette-Guerin vaccination scar after receiving a dose of messenger RNA vaccine against SARS-CoV-2Lim, Darren Wan-Teck ; Ng, Dorothy Hui Lin ; Low, Jenny Guek-Hong 
1030-Mar-2021Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutationsChang, Gee-Chen; Lam, David Chi-Leung; Tsai, Chun-Ming; Chen, Yuh-Min; Shih, Jin-Yuan; Aggarwal, Shyam; Wang, Shuhang; Kim, Sang-We; Kim, Young-Chul; Wahid, Ibrahim; Li, Rubi; Lim, Darren Wan-Teck ; Sriuranpong, Virote; Chan, Raymond Tsz-Tong; Lorence, Robert M; Carriere, Philippe; Raabe, Christina; Cseh, Agnieszka; Park, Keunchil
111-Apr-2019First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the 'real-world' clinical settingPark, Keunchil; Lim, Darren Wan-Teck ; Okamoto, Isamu; Yang, James Chih-Hsin
923-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesTan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
9324-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018)Tan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
942-Oct-2019Liquid biopsy: one cell at a timeLim, Su Bin; Lee, Wen Di ; Vasudevan, Jyothsna; Lim, Wan-Teck ; Lim, Chwee Teck 
9529-Feb-2016Microfluidic enrichment for the single cell analysis of circulating tumor cellsYeo, Trifanny ; Tan, Swee Jin; Lim, Chew Leng; Lau, Dawn Ping Xi; Chua, Yong Wei; Krisna, Sai Sakktee; Iyer, Gopal ; Tan, Gek San ; Lim, Tony Kiat Hon; Tan, Daniel SW ; Lim, Wan-Teck ; Lim, Chwee Teck 
9622-May-2019Pan-cancer analysis connects tumor matrisome to immune responseLim, Su Bin; Chua, Melvin Lee Kiang ; Yeong, Joe Poh Sheng; Jin, Swee Jin; Lim, Wan-Teck ; Lim, Chwee Teck 
9730-Dec-2019Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohortsBang, Yung-Jue; Su, Wu-Chou; Schuler, Martin; Nam, Do-Hyun; Lim, Wan Teck ; Bauer, Todd M; Azaro, Analia; Poon, Ronnie Tung Ping; Hong, David; Lin, Chia-Chi; Akimov, Mikhail; Ghebremariam, Samson; Zhao, Sylvia; Giovannini, Monica; Ma, Brigette
981-Jun-2018Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLCTan, Eng-Huat ; Lim, Wan-Teck ; Ahn, Myung-Ju; Ng, Quan-Sing ; Ahn, Jin Seok; Tan, Daniel Shao-Weng ; Sun, Jong-Mu; Han, May; Payumo, Francis C; Mckee, Krista; Yin, Wei; Credi, Marc; Agarwal, Shefali; Jac, Jaroslaw; Park, Keunchil
991-Nov-2021Prognostic Matrisomal Gene Panel and Its Association with Immune Cell Infiltration in Head and Neck CarcinomasBelotti, Yuri ; Lim, Su Bin; Iyer, Narayanan Gopalakrishna ; Lim, Wan-Teck ; Lim, Chwee Teck 
1001-Nov-2017Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)Nokihara, H; Lu, S; Mok, TSK; Nakagawa, K; Yamamoto, N; Shi, YK; Zhang, L; Soo, RA ; Yang, JC; Sugawara, S; Nishio, M; Takahashi, T; Goto, K; Chang, J; Maemondo, M; Ichinose, Y; Cheng, Y; Lim, WT ; Morita, S; Tamura, T